Feedback / Questions
Erbitux (cetuximab) - Eli Lilly
Braftovi (encorafenib) - Pfizer
azenosertib (ZN-c3) - Zentalis Pharma
http://clinicaltrials.gov/ct2/show/NCT05743036
Aug 18, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next